Advertisement

Reactions Weekly

, Volume 1735, Issue 1, pp 11–11 | Cite as

Nivolumab in melanoma: immune-related adverse events and efficacy

Clinical study
  • 25 Downloads

Reference

  1. Okada N, et al. Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study. Clinical Therapeutics : 6 Dec 2018. Available from: URL: http://doi.org/10.1016/j.clinthera.2018.11.004

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations